Matched Pair Comparison of Busulfan/Cyclophosphamide/Etoposide (BuCyE) to Carmustine/Etoposide/Cytarabine/Melphalan (BEAM) Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation (autoHCT) for Lymphoma

被引：3

作者：

Pasquini, Marcelo C. ^{[1
]}

Le Rademacher, Jennifer ^{[2
]}

Flowers, Christopher ^{[3
]}

Lill, Michael ^{[4
]}

Costa, Luciano J. ^{[5
]}

Shore, Tsiporah B. ^{[6
]}

Vaughan, William ^{[7
]}

Craig, Michael ^{[8
]}

Freytes, Cesar O. ^{[9
,10
]}

Shea, Thomas C. ^{[11
]}

Horwitz, Mitchell E. ^{[12
]}

Fay, Joseph W. ^{[13
]}

Mineishi, Shin ^{[14
]}

Rondelli, Damiano ^{[15
]}

Mason, James ^{[16
]}

Reddy, Vijay ^{[17
]}

Braunschweig, Ira ^{[18
]}

Ai, Weiyun ^{[19
]}

Armstrong, Elizabeth ^{[20
]}

Smith, Angela ^{[20
]}

Zhao, Cathy ^{[20
]}

Elekes, Agnes ^{[20
]}

Carreras, Jeanette ^{[1
]}

Kato, Kazunobu ^{[20
]}

Waller, Edmund K. ^{[3
]}

机构：

[1] Med Coll Wisconsin, CIBMTR, Milwaukee, WI 53226 USA

[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[3] Emory Univ, Div BMT, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[5] Med Univ S Carolina, Charleston, SC 29425 USA

[6] New York Hosp, Cornell Med Ctr Hematol Oncol, New York, NY 10021 USA

[7] Univ Alabama Birmingham, Bone Marrow Transplantat & Cell Therapy Program, Birmingham, AL USA

[8] W Virginia Univ, Hlth Sci Ctr, Morgantown, WV 26506 USA

[9] South Texas Vet Hlth Care Syst, San Antonio, TX USA

[10] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA

[11] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC USA

[12] Duke Univ, Med Ctr, Dept Med, Adult Stem Cell Transplant Program,Div Cellular T, Durham, NC 27710 USA

[13] Baylor Univ, Med Ctr, Dallas, TX USA

[14] Univ Alabama Birmingham, Bone Marrow Transplantat Program, Birmingham, AL USA

[15] Univ Illinois Hosp & Hlth Sci Syst, Dept Med, Sect Hematol Oncol, Chicago, IL USA

[16] Scripps Clin, La Jolla, CA 92037 USA

[17] Univ Florida, Gainesville, FL USA

[18] Montefiore Med Ctr, Bronx, NY 10467 USA

[19] Univ Calif San Francisco, San Francisco, CA 94143 USA

[20] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2014年 / 20卷 / 02期

关键词：

D O I：

10.1016/j.bbmt.2013.12.259

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

232

引用

页码：S162 / S162

页数：1

共 50 条

[31] High dose melphalan (HDM) is superior to cyclophosphamide plus etoposide and busulfan (CVB) as the conditioning regimen in autologous stem cell transplantation for multiple myeloma
谷景立
ChinaMedicalAbstracts(InternalMedicine), 2019, 36 (04) : 230 - 231
[32] Progenitor cell transplantation (PCT) in children with a conditioning regimen of busulfan, cyclophosphamide and etoposide.
Mustafa, MM
El Solh, H
Ayas, M
Al-Mahr, M
Al-Jefri
BLOOD, 1998, 92 (10) : 353B - 353B
[33] Low toxicity profile of the combination of carmustine, etoposide, cytarabine, and cyclophosphamide (BEAC) as an alternative conditioning regimen in autologous haematopoietic cell transplantation for lymphoma patients: a single center's experience
Sakellari, I.
Constantinou
Varnavas
Bouziana, S.
Mallouri, D.
Vardi, A.
Marvaki, A.
Papadopoulou, D.
Batsis, I.
Anagnostopoulos, A.
BONE MARROW TRANSPLANTATION, 2017, 52 : S330 - S331
[34] Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma
M Benekli
S L Smiley
T Younis
M S Czuczman
F Hernandez-Ilizaliturri
B Bambach
M Battiwalla
S Padmanabhan
P L McCarthy
T Hahn
Bone Marrow Transplantation, 2008, 41 : 613 - 619
[35] Autologous Stem Cell Transplantation with Bendaeam (Bendamustine, Etoposide, Cytarabine, Melphalan) As Conditioning Regimen for Non-Hodgkin's Lymphoma and Hodgkin's Lymphoma
Garciaz, Sylvain
Coso, Diane
Broussais, Florence
Schiano, Jean-Marc
Calmels, Boris
Saillard, Colombe
Boudin, Lauris
Amrane, Sophie
Blaise, Didier
Bouabdallah, Reda
BLOOD, 2014, 124 (21)
[36] Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma
Benekli, M.
Smiley, S. L.
Younis, T.
Czuczman, M. S.
Hernandez-Ilizaliturri, F.
Bambach, B.
Battiwalla, M.
Padmanabhan, S.
McCarthy, P. L., Jr.
Hahn, T.
BONE MARROW TRANSPLANTATION, 2008, 41 (07) : 613 - 619
[37] Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen for autologous stem cell transplantation in Hodgkin's lymphoma patients
Bicim, Soykan
Erkurt, Mehmet Ali
Kuku, Irfan
Kaya, Emin
Berber, Ilhami
Kaya, Ahmet
Hidayet, Emine
Uysal, Ayse
Sarici, Ahmet
Ozen, Ilknur Nizam
IRAQI JOURNAL OF HEMATOLOGY, 2024, 13 (01) : 1 - 6
[38] High-dose etoposide, cytarabine and melphalan as conditioning regimen for autologous stem cell transplantation in patients with refractory or relapsed Hodgkin's lymphoma
Bekadja, M. A.
Osmani, S.
Brahimi, M.
Talhi, S.
Bekadja, S.
Belkhodja, S.
BONE MARROW TRANSPLANTATION, 2012, 47 : S446 - S446
[39] Melphalan vs Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) As Preparative Regimen for Newly Diagnosed Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Namburi, Swathi
Bailey, Megumi
Tsomo, Tenzin
Neil, Bailey
Lu, Chiachun
Egan, Daniel
Patel, Krish
Bensinger, William
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S238 - S238
[40] Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas
Jo, Jae-Cheol
Kim, Jin-Seok
Lee, Je-Hwan
Lee, Jung-Hee
Im, Seong Nam
Lee, Sang-Min
Yoon, Sung-Soo
Kim, In-Ho
Bae, Seong Hwa
Lee, Yoo Jin
Choi, Yunsuk
Lee, Won-Sik
ANNALS OF HEMATOLOGY, 2021, 100 (01) : 189 - 196

← 1 2 3 4 5 →